Cargando…

Urinary mRNA biomarker panel for the detection of urothelial carcinoma

The early detection of bladder cancer is important as the disease has a high rate of recurrence and progression. The development of accurate, non-invasive urinary assays would greatly facilitate detection. In previous studies, we have reported the discovery and initial validation of mRNA biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urquidi, Virginia, Netherton, Mandy, Gomes-Giacoia, Evan, Serie, Daniel, Eckel-Passow, Jeanette, Rosser, Charles J., Goodison, Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122424/ https://www.ncbi.nlm.nih.gov/pubmed/27231851 http://dx.doi.org/10.18632/oncotarget.9587

Ejemplares similares

A microRNA biomarker panel for the non-invasive detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2016)

IL-8 as a urinary biomarker for the detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
por: Miyake, Makito, et al.
Publicado: (2013)

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection
por: Miyake, Makito, et al.
Publicado: (2013)

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
por: Goodison, Steve, et al.
Publicado: (2013)

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
por: Zhang, Ge, et al.
Publicado: (2014)

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
por: Miyake, Makito, et al.
Publicado: (2013)

Influencing factors on the NMP-22 urine assay: an experimental model
por: Miyake, Makito, et al.
Publicado: (2012)

Complete Genome Sequence of Mycoplasma hyorhinis Strain SK76
por: Goodison, Steve, et al.
Publicado: (2013)

A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
por: Goodison, Steve, et al.
Publicado: (2012)

CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines
por: Goodison, Steve, et al.
Publicado: (2003)

Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status
por: Wang-Rodriguez, Jessica, et al.
Publicado: (2003)

Simultaneous multi-analyte urinary protein assay for bladder cancer detection
por: Rosser, Charles J, et al.
Publicado: (2014)

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma
por: Eckel-Passow, Jeanette E, et al.
Publicado: (2014)

Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology
por: Khalbuss, Walid, et al.
Publicado: (2006)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
por: Gomes-Giacoia, Evan, et al.
Publicado: (2014)

Peroxiredoxins - Urinary Surveillance Biomarkers in Urothelial Cancer
por: Kumari, Nitu, et al.
Publicado: (2022)

Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs
por: Tsamouri, Maria Malvina, et al.
Publicado: (2022)

Glioma: interaction of acquired and germline genetics
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2021)

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2020)

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort
por: Goodison, Steve, et al.
Publicado: (2016)

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
por: Eckel‐Passow, Jeanette E., et al.
Publicado: (2019)

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
por: McNeil, Brian K, et al.
Publicado: (2014)

Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors
por: Zhang, Ge, et al.
Publicado: (2014)

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders
por: Chen, Jian-jun, et al.
Publicado: (2018)

Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma
por: Furuya, Hideki, et al.
Publicado: (2019)

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
por: Ho, Thai Huu, et al.
Publicado: (2017)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
por: Avogbe, Patrice Hodonou, et al.
Publicado: (2019)

Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis
por: Ariza, Xavier, et al.
Publicado: (2015)

Analysis of a Urinary Biomarker Panel for Obstructive Nephropathy and Clinical Outcomes
por: Xie, Yuanyuan, et al.
Publicado: (2014)

Novel urinary protein biomarker panel for early diagnosis of gastric cancer
por: Shimura, Takaya, et al.
Publicado: (2020)

Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform
por: Eckel-Passow, Jeanette E, et al.
Publicado: (2011)

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
por: Schuettfort, Victor M., et al.
Publicado: (2021)

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer
por: Masuda, Norihiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a3173nv29gqp00daasq9ukur94